Jacobs Levy Equity Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-595,016
| Closed | -$1.32M | – | 980 |
|
|
2024
Q2 | $1.32M | Sell |
595,016
-109,081
| -15% | -$242K | 0.01% | 676 |
|
|
2024
Q1 | $1.89M | Sell |
704,097
-353,787
| -33% | -$948K | 0.01% | 606 |
|
|
2023
Q4 | $3.16M | Sell |
1,057,884
-1,206,475
| -53% | -$3.61M | 0.02% | 514 |
|
|
2023
Q3 | $2.22M | Buy |
2,264,359
+1,836,567
| +429% | +$1.8M | 0.01% | 544 |
|
|
2023
Q2 | $595K | Buy |
427,792
+272,289
| +175% | +$378K | ﹤0.01% | 789 |
|
|
2023
Q1 | $247K | Buy |
155,503
+9,484
| +6% | +$15.1K | ﹤0.01% | 885 |
|
|
2022
Q4 | $910K | Buy |
+146,019
| New | +$910K | 0.01% | 691 |
|
|
2021
Q1 | – | Sell |
-35,072
| Closed | -$912K | – | 1048 |
|
|
2020
Q4 | $912K | Buy |
35,072
+120
| +0.3% | +$3.12K | 0.01% | 746 |
|
|
2020
Q3 | $1.3M | Sell |
34,952
-3,668
| -9% | -$136K | 0.01% | 606 |
|
|
2020
Q2 | $1.98M | Buy |
38,620
+461
| +1% | +$23.7K | 0.02% | 534 |
|
|
2020
Q1 | $1.2M | Sell |
38,159
-3,088
| -7% | -$97.4K | 0.02% | 583 |
|
|
2019
Q4 | $2.46M | Buy |
41,247
+8,937
| +28% | +$533K | 0.02% | 510 |
|
|
2019
Q3 | $1.18M | Buy |
32,310
+1,260
| +4% | +$46.2K | 0.01% | 592 |
|
|
2019
Q2 | $1.44M | Sell |
31,050
-670
| -2% | -$31.2K | 0.02% | 577 |
|
|
2019
Q1 | $1.27M | Buy |
31,720
+23,570
| +289% | +$947K | 0.02% | 613 |
|
|
2018
Q4 | $375K | Buy |
8,150
+300
| +4% | +$13.8K | 0.01% | 778 |
|
|
2018
Q3 | $348K | Buy |
+7,850
| New | +$348K | ﹤0.01% | 847 |
|
|
2016
Q2 | – | Sell |
-18,500
| Closed | -$313K | – | 1172 |
|
|
2016
Q1 | $313K | Buy |
+18,500
| New | +$313K | 0.01% | 860 |
|